6431 - 6440 of 8823 Results
Title
Year
-
OPENTitle: Mental health in people with Parkinson’s disease during the COVID-19 pandemic: potential for targeted interventions?Journal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page: 95End Page: 95Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00238-yBest OA location URL: https://www.nature.com/articles/s41531-021-00238-y.pdfCitation Count: 20
-
OPENTitle: Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson’s Disease and DyskinesiaJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 2Start Page: 739End Page: 751Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00256-1Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00256-1.pdfCitation Count: 13
-
OPENTitle: Altered conformation of α-synuclein drives dysfunction of synaptic vesicles in a synaptosomal model of Parkinson’s diseaseJournal Name: Cell ReportsPublisher: Elsevier BVVol: 36Issue #: 1Start Page: 109333End Page: 109333Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2021.109333Best OA location URL: http://www.cell.com/article/S2211124721007099/pdfCitation Count: 45
-
OPENTitle: Herpesvirus Infections and Risk of Parkinson’s DiseaseJournal Name: Neurodegenerative DiseasesPublisher: S. Karger AGVol: 20Issue #: 2-3Start Page: 97End Page: 103Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1159/000512874Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8552529Citation Count: 28
-
OPENTitle: Psychometric properties of the Beck Depression Inventory‐II in progressive supranuclear palsyJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 10Start Page: e2344End Page: e2344Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2344Best OA location URL: https://doi.org/10.1002/brb3.2344Citation Count: 13
-
OPENTitle: Pathogenic LRRK2 control of primary cilia and Hedgehog signaling in neurons and astrocytes of mouse brainJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.67900Best OA location URL: https://doi.org/10.7554/elife.67900Citation Count: 101
-
OPENTitle: Rapid Dynamic Naturalistic Monitoring of Bradykinesia in Parkinson’s Disease Using a Wrist-Worn AccelerometerJournal Name: SensorsPublisher: MDPI AGVol: 21Issue #: 23Start Page: 7876End Page: 7876Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/s21237876Best OA location URL: https://escholarship.org/uc/item/20s549zmCitation Count: 32
-
OPENTitle: [18F]Nifene PET/CT Imaging in Mice: Improved Methods and Preliminary Studies of α4β2* Nicotinic Acetylcholinergic Receptors in Transgenic A53T Mouse Model of α-Synucleinopathy and Post-Mortem Human Parkinson’s DiseaseJournal Name: MoleculesPublisher: MDPI AGVol: 26Issue #: 23Start Page: 7360End Page: 7360Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/molecules26237360Best OA location URL: https://escholarship.org/uc/item/0kq0s571Citation Count: 18
- The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease2021OPENTitle: The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 10Start Page: 3114End Page: 3125Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awab191Best OA location URL: https://academic.oup.com/brain/article-pdf/144/10/3114/41381603/awab191.pdfCitation Count: 168
-
OPENTitle: Disease Duration Influences Gene Expression in Neuromelanin-Positive Cells From Parkinson’s Disease PatientsJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page: 763777End Page: 763777Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2021.763777Best OA location URL: https://doi.org/10.3389/fnmol.2021.763777Citation Count: 21